Brain Cancer Trial, Recruiting NCT04692324 Sponsor: Mayo Clinic Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT04692324
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have any sign of a tumour or growth affecting the brain, spine, nerves, blood vessels, or the membranes surrounding the brain and spinal cord — whether confirmed as cancer, non-cancerous, or not yet classified
  • People who are 18 years of age or older

Who may not be able to join:

  • People who are under 18 years of age
  • People who belong to a vulnerable population group
  • Women who are pregnant or who may be pregnant
  • People for whom there is no clinical or scan-based evidence of a possible tumour or growth in the central nervous system
  • People who are unable or unwilling to provide written consent, and for whom no legally authorised representative is available to provide consent on their behalf (note: if a legally authorised representative is available for someone who cannot consent for themselves, an exception may be considered — confirm with trial site)
  • People for whom the medical procedure used to collect fluid from around the brain or spinal cord would be considered unsafe — for example, those with a large mass in the lower part of the brain that poses a risk of dangerous pressure shifts, or those with a blood clotting problem, or any other medical reason that makes this type of procedure inadvisable (confirm with trial site for specific situations)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Terry C. Burns, MD, PhD, Mayo Clinic in Rochester

Phone: 855-776-0015

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
14 January 2021
Est. completion
31 December 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Collection cerebrospinal fluid (CSF) samples that can provide a resource to the research community for biomarker discovery

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov